KPV vs VIP

Name: KPV vs VIP
Published: 2026-10-24

Updated Oct 24, 20269 sources

Key differences

1VIP is a 28-amino-acid neuropeptide acting on blood vessels, airways and immune cells, with some human data. KPV is a three-amino-acid alpha-MSH fragment studied for gut and skin inflammation, mostly in animals.

Facts from each record, in the same words as their own pages.

KPV and VIP side by side
	KPV	VIP
Category	Immune, Healing & recovery	Immune, Other
Evidence	Animal data only	Limited human data
FDA status	Not FDA approvedRegulatory	FDA 503A Category 1Regulatory
WADA	Not confirmed	Not confirmed
Half-life	Not published for humans. Unmodified tripeptides are cut by blood enzymes within minutes. Figures online from 15 minutes to 24 hours have no source.Competitor guide	About 1 minute in the blood after IV infusion in healthy volunteers. Enzymes such as NEP and DPP-IV break it down fast.Clinical study
Routes	Subcutaneous injection, Oral, Topical, Nasal, Other route	Nasal, Subcutaneous injection, Other route
Forms	Vial (powder), Capsule	Nasal spray, Vial (powder), Other form
Reported doses	200 to 500 mcg (subcutaneous injection) 0.5 to 2 mg (subcutaneous injection) 100 to 500 mcg (oral)	50 to 200 mcg (nasal) 50 to 500 mcg (subcutaneous injection) 25 to 100 mcg (other route)
Most cited frequency	Once daily	Once or twice daily
Vial sizes	5 mg, 10 mgCompetitor guide	10 mg, 5 mgCompetitor guide
Mixed vial keeps	Fridge at 2 to 8 C, not frozen.Competitor guide	Fridge at 2 to 8 C, not frozen.Competitor guide
Protocols on file	18	15

Doses shown are what sources report, labelled by origin. Not medical advice.

9 sources, each checked by date. Record updated Oct 24, 2026. Numbers are restated in our own words and labelled by where they came from.